Vice President, Safety and PV, Moderna, United States
Dr. Straus’ team oversees global clinical safety for investigational products as well as post-licensure safety monitoring and assessment for the Merck portfolio in vaccines and infectious disease therapeutics. He is trained as an internist, gastroenterologist, and epidemiologist...
Read More →RS
Group Medical Director, Medical Safety Evaluation, AbbVie, United States
Have extensive experience in both post-marketing and clinical trials in pharmacovigilance for 15 years. In-depth global filing experience as a safety lead for both small molecule and biologics. Intimate knowledge of processes and regulations in ICSR, aggregate reporting and signal...
Read More → LL
Associate Principal Biostatistician, Merck & Co., Inc., United States
Li-An Lin is associate principal biostatistician supporting late stage oncology and general medicine therapeutic areas at Merck. Prior to Merck, he received a PhD degree in biostatistics from The University of Texas at Houston. Dr. Lin’s research areas include safety signal detection...
Read More → BE
Adjunct Professor, Columbia University; Senior Director, Pfizer Inc, United States
Birol Emir, PhD, is Senior Director and RWE Statistics Group Lead in the Statistical Research and Data Science Center at Pfizer Inc. In addition, he is a lecturer at Columbia University in New York and External PhD Committee Member at Rutgers University. Recently, his primary focuses...
Read More →